terikalant
experimental class II antiarrhythmic drug; RN gioven refers to terikalant ((S-(-))-isomer)
Also Known As:
1-(2-(3,4-dihydro-2H-1-benzopyran-4-yl)ethyl)-4-(3,4-dimethoxyphenyl)piperidine; RP 58866; RP 62719; RP-58866; RP-62719; RP62719; terikalant hydrochloride; terikalant, RP 62719
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Ventricular Tachycardia
05/01/1992
- " In the remaining 12 hearts (heptanol, n = 2; potassium, n = 3; tetrodotoxin, n = 2; RP62719, n = 2; flecainide, n = 1; and propafenone, n = 2), termination of ventricular tachycardia occurred by collision of the circulating impulse with a spontaneous antidromic wave front reflected within the circuit. " 05/01/1992
- " Increasing doses of heptanol (n = 10), potassium (n = 10), tetrodotoxin (n = 6), RP62719 (a new class III drug) (n = 4), flecainide (n = 5), and propafenone (n = 5) were administered to terminate ventricular tachycardia. "
|
2. | Torsades de Pointes (Torsade de Pointes)
|
3. | Ventricular Fibrillation
|
4. | Bradycardia
|
5. | Cardiac Arrhythmias (Arrythmia)
|
|
Related Drugs and Biologics
Related Therapies and Procedures